Past Events

Leveraging Real-World Treatment Experience from EA Protocols
See Event Highlights and Download the Meeting Report 
Expanded Access Programs and Real-World Evidence: Public Meeting
Expanded access programs, sometimes also called “compassionate use” programs, provide patients with serious or immediately life-threatening diseases or conditions access to investigational products outside of clinical tria
2023 Innovations in Regulatory Science Awards
RDBA and FDA Foundation Partner to Provide Turnkey Resources to Retail Dietitians - The Associated Press
Today, the Reagan-Udall Foundation for the FDA (FDA Foundation) and the Retail Dietitians Business Alliance (RDBA) jointly launched Supporting Healthier Eating in the New Normal: The Ultimate Retail Dietitians Toolkit.
Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments - The Journal Drugs
More than 32 million individuals have survived a confirmed COVID-19 viral infection in the USA [1, 2], and a substantial proportion of post-COVID survivors are suffering from prolonged, recurrent, and/or newly emerging symptoms that span across bodily systems and organs [3]. The spectrum of symptoms and disabilities observed in this setting has been alarming and suggests that the “post-COVID syndrome” is a pan-inflammatory disease with highly variable disease expression and consequences [4]. However, accurately and completely characterizing post-COVID syndrome is difficult because many individuals with acute COVID-19 infection were not hospitalized, and therefore were not tracked through standard, in-patient-based data reporting mechanisms to public health authorities [5].
FDA’s Vaccine Efforts Expand to Developing Public Confidence - American Medical Association
Scientists at the Food and Drug Administration (FDA) have devoted countless hours to ensuring that the COVID-19 vaccines being deployed and those in the development pipeline are safe and effective.
Industry Voices — COVID-19 vaccine development was a historic achievement. We'll need cutting-edge technology to make sure it ends the pandemic - Fierce Healthcare
After nine months of suffering, isolation and economic downturn on an unprecedented international scale, the expedited development and approval of COVID-19 vaccines has shown us the light at the tunnel’s end.
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
In recent months, scientists and policymakers around the globe have rallied together with one common goal: to eliminate Covid-19.
Vaccine hesitancy part 2: Effective strategies for a human-centered health campaign - Atlantic Council
Trust is health’s most valuable player COVID-19 has made clear that the 
Leading Health Care and Infectious Disease Experts Join Together to Discuss COVID-19 Vaccine Safety, Equity and Distribution - Associated Press
December 17, 2020 (Washington, D.C.) As Americans patiently await their turn for COVID-19 vaccination, a group of leading medical, health equity and public policy experts discussed and an